Contemporary Management of Pancreatic Cancer

An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.

Reviews how recent advances in surgery, radiation therapy, ablative options, and endovascular therapies have brought promise and hope to patients with pancreatic cancer. The RenovoCath is highlighted as a potential endovascular therapy procedure in the management of pancreatic cancer now available through the Phase III TIGeR-PaC Clinical Trial.

Read the full article

Previous Post
Woman Receiving Experimental Treatments For Pancreatic Cancer At UPMC
Menu